DCE-MRI: Vascularity Assessment in Oncology and Neurology
*Corresponding Author: Dr. Valeria Conti, Department of MRI Research, San Marino Medical Institute, San Marino, Email: v.conti@dcmri.smReceived Date: Nov 03, 2025 / Published Date: Nov 28, 2025
Citation: Conti DV (2025) DCE-MRI: Vascularity Assessment in Oncology and Neurology. J Radiol 14: 747.DOI: 10.4172/2167-7964.1000747
Copyright: © 2025 Dr. Valeria Conti This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Abstract
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) is a powerful technique for assessing tissue vascularity and permeability in various clinical applications, especially oncology and neurology. It analyzes signal changes after contrast agent injection to differentiate tissues and guide diagnosis and treatment. Pharmacokinetic modeling, including the Tofts model, is essential for quantitative analysis. DCE-MRI plays a critical role in brain tumor characterization and prostate cancer staging. Advances in acquisition, analysis, and AI integration are enhancing its capabilities, while challenges in standardization and interpretation are being addressed. The technique is also vital for monitoring treatment response and differentiating lesions, with ongoing research into novel contrast agents.
